October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 16th 2024
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
October 15th 2024
The conference’s opening keynote sets the scene for 2025 and the years to come.
September 30th 2024
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
The impact of Covid-19 across market access stakeholders and what it means for manufacturers
Pharma marketing will have to adjust to a new reality
Copay maximizers have murky financial implications, says Drug Channels
The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions
How to successfully transition patient solutions providers
Reasons for, and actions to take, when switching hub service providers
Integrichain adds more managed services to its commercialization IT business
Acquisition of Cumberland Life Sciences boosts its client base and range of services
Patient support in the pandemic era
Hub service providers look to telehealth to expand patient connectivity
Navigating the patient journey after rare disease diagnosis
Commercial teams can prepare for overcoming predictable hurdles
Evolving Patient Access Programs for Specialty Therapies
When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Tips on running virtual meetings
For sessions with co-workers or clients, consider these recommendations
Sales growth of pharmaceuticals is slowing globally, says IQVIA annual study
US list-price sales reached $510 billion in 2019
Specialty pharmaceutical patients ‘have difficulty’ obtaining their first dose
CoverMyMeds report gives evidence of ongoing difficulties in patient support
Pondering the shrinking number of retail pharmacies
PCMA study disputes its members’ harm to brick-and-mortar businesses
2020 Patient Support / Hub Services Report
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
‘Drugs to Watch’ list tags 11 about-to-be-approved therapies with blockbuster potential
Clarivate Analytics predicts both approvals and commercial potential
Eversana takes on a full-scale pharma commercialization
Deal with Evoke Pharmaceuticals anticipates FDA approval
Another go at consumer-level blood testing for chronic disease
Finland’s Nightingale Health opens a blood-draw center for consumers in Helsinki
Gathering to take stock of hub services
CBI meeting will highlight new advances in market access via hub services
Conduent proposes an augmented-reality linkage to prescription containers
Transforming the container to an interactive portal
PhRMA, Pacific Research studies document lower revenue growth for US pharma
Medvantx doubles capacity at its ‘end of runway’ pharmacy
Location near UPS’ WorldPort hub in Louisville, KY, enables fast prescription turnarounds
Another go at value-based therapy models for CGTs
ARM-sponsored study projects a 23% reduction in the cost of treating blood diseases in 2029 by administering cellular and genetic therapies
Eversana combines business assets to form a full-services marketing agency
Eversana Engage will ‘seamlessly’ integrate marketing support with the company’s commercial services
Senators lambast Eli Lilly’s Lispro authorized-generic program
The ‘broken promise’ of lower-cost insulin, according to Senators Warren and Blumenthal
Oncologist survey finds value in pharma rep interactions
Cardinal Specialty Health Solutions survey probes reps' value, use of RWE
TrialCard builds out its market access services with Policy Reporter
Latest acquisition adds data on payer policies, formularies and prior authorizations
Patient support services: more of them in 2019, but compliance uncertainties persist
Helio Health survey sees nagging compliance problems
Payers are only slowly comprehending real-world evidence (RWE) in coverage determinations
Syneos Health survey of P&T committees see further progress in Europe than in the US
Survey sponsored by Merck KGaA sees lack of diabetes knowledge in much of the world
November 14 is World Diabetes Day
Human Care Systems upgrades its patient-support software
Version 5.0 of Resilix platform includes more use-cases
Accelerating the drive toward patient centricity
Getting away from the traditional product-centric management structure is not easy; here’s how to do it
Deloitte’s ConvergeHealth announces a new patient-centered IT platform
Updates its Patient Connect platform with new interactive capabilities